• AtriCure director Karen N. Prange sold 3,000 shares of common stock on May 20, 2026 at a weighted average price of $28.65.
• Prange’s direct holdings fell to 26,373 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AtriCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001566083-26-000004), on May 22, 2026, and is solely responsible for the information contained therein.